Atlas Trials

An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial

Clinical trial NCT04343768 · COMPLETED

Trial details

NCT number
NCT04343768
Sponsor
Shahid Beheshti University of Medical Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-04-09
Primary completion
2020-04-27
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.